感染或接种疫苗后的抗RBDIgG动态
Amira Harrache1, Kahina Saker2, Bouchra Mokdad2
1Biostatistics Department, Hospices Civils de Lyon, Lyon France. CNRS, UMR 5558, University of Lyon, Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, 69100 Villeurbanne, France.
对SARS-CoV-2的抗体反应在感染和接种疫苗之间有所不同. 接种疫苗会显著提高抗体水平,而感染会导致持久抗体,而BMI和年龄等因素会影响反应.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 了解SARS-CoV-2抗体动态对于优化疫苗疗效和公共卫生战略至关重要.
- 在感染和接种疫苗后,抗体水平和寿命显著不同.
研究的目的:
- 调查影响SARS-CoV-2抗体运动的关键因素感染后和接种疫苗后.
- 为了比较自然感染和不同疫苗接种方案之间的抗体标位峰值和IgG半衰期.
主要方法:
- 对来自375名医疗保健工作者1340个样本进行了纵向分析.
- 峰值血清反应和IgG半衰期的表征.
- 对抗体运动的临床和人口因素 (BMI,年龄,吸烟) 的评估.
主要成果:
- 与自然感染相比,两剂疫苗接种后的抗体标位峰值大约是自然感染的20倍.
- 自然感染导致抗体半衰期比两剂疫苗更长.
- 临床因素如BMI,年龄和吸烟影响了抗体反应的峰值,但不是抗RBDIgG半衰期.
- 与第二剂相比,第三剂mRNA疫苗增加了抗体标位峰值和延长了半衰期.
结论:
- SARS-CoV-2抗体动力学是多样化的,并受到免疫接种的类型和数量的影响.
- 临床因素在塑造抗体反应峰值方面发挥着作用.
- 疫苗接种策略,包括强剂量,可以调节抗体动态,从而提高潜在的保护.
更多相关视频
07:54Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test
Published on: January 19, 2024
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
相关概念视频
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Cross-reactivity
Vaccinations
Rh Blood Group
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
